New horizons in multimorbidity in older adults

Alison J. Yarnall; Avan A. Sayer; Andrew Clegg; Kenneth Rockwood; Stuart Parker; John V. Hindle

doi:10.1093/ageing/afx150

New horizons in multimorbidity in older adults

Alison J. Yarnall, Avan A. Sayer, Andrew Clegg, Kenneth Rockwood, Stuart Parker, John V. Hindle

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

239 Citas (Scopus)

Resumen

The concept of multimorbidity has attracted growing interest over recent years, and more latterly with the publication of specific guidelines on multimorbidity by the National Institute for Health and Care Excellence (NICE). Increasingly it is recognised that this is of particular relevance to practitioners caring for older adults, where multimorbidity may be more complex due to the overlap of physical and mental health disorders, frailty and polypharmacy. The overlap of frailty and multimorbidity in particular is likely to be due to the widespread health deficit accumulation, leading in some cases to functional impairment. The NICE guidelines identify 'target groups' who may benefit from a tailored approach to care that takes their multimorbidity into account, and make a number of research recommendations. Management includes a proactive individualised assessment and care plan, which improves quality of life by reducing treatment burden, adverse events, and unplanned or uncoordinated care.

Idioma original	English
Páginas (desde-hasta)	882-888
Número de páginas	7
Publicación	Age and Ageing
Volumen	46
N.º	6
DOI	https://doi.org/10.1093/ageing/afx150
Estado	Published - nov. 1 2017

Nota bibliográfica

Funding Information:
Kenneth Rockwood is President and Chief Science Officer of DGI Clinical, which has contracts with pharma on individualised outcome measurement. In July 2015 he gave a lecture at the Alzheimer Association International Conference in a symposium sponsored by Otsuka and Lundbeck. At that time he presented at an Advisory Board meeting for Nutricia. In 2017 he attended an advisory board meeting for Lundbeck. He is a member of the Research Executive Committee of the Canadian Consortium on Neurodegeneration in Aging, which is funded by the Canadian institutes of Health Research, with additional funding from the Alzheimer Society of Canada and several other charities, as well as from Pfizer Canada and Sanofi Canada. He receives career support from the Dalhousie Medical Research Foundation as the Kathryn Allen Weldon Professor of Alzheimer Research, and research support from the Nova Scotia Health Research Foundation, the Capital Health Research Fund and the Fountain Family Innovation Fund of the Nova Scotia Health Authority Foundation. The other authors have no conflicts of interest to report.

Funding Information:
The research was supported by the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.

Publisher Copyright:
© The Author 2017. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved.

ASJC Scopus Subject Areas

Ageing
Geriatrics and Gerontology

PubMed: MeSH publication types

Journal Article
Review
Research Support, Non-U.S. Gov't

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1093/ageing/afx150

Otros archivos y enlaces

Citar esto

@article{eed65d7e69394685ac3c06a7c1977904,

title = "New horizons in multimorbidity in older adults",

abstract = "The concept of multimorbidity has attracted growing interest over recent years, and more latterly with the publication of specific guidelines on multimorbidity by the National Institute for Health and Care Excellence (NICE). Increasingly it is recognised that this is of particular relevance to practitioners caring for older adults, where multimorbidity may be more complex due to the overlap of physical and mental health disorders, frailty and polypharmacy. The overlap of frailty and multimorbidity in particular is likely to be due to the widespread health deficit accumulation, leading in some cases to functional impairment. The NICE guidelines identify 'target groups' who may benefit from a tailored approach to care that takes their multimorbidity into account, and make a number of research recommendations. Management includes a proactive individualised assessment and care plan, which improves quality of life by reducing treatment burden, adverse events, and unplanned or uncoordinated care.",

author = "Yarnall, {Alison J.} and Sayer, {Avan A.} and Andrew Clegg and Kenneth Rockwood and Stuart Parker and Hindle, {John V.}",

note = "Funding Information: Kenneth Rockwood is President and Chief Science Officer of DGI Clinical, which has contracts with pharma on individualised outcome measurement. In July 2015 he gave a lecture at the Alzheimer Association International Conference in a symposium sponsored by Otsuka and Lundbeck. At that time he presented at an Advisory Board meeting for Nutricia. In 2017 he attended an advisory board meeting for Lundbeck. He is a member of the Research Executive Committee of the Canadian Consortium on Neurodegeneration in Aging, which is funded by the Canadian institutes of Health Research, with additional funding from the Alzheimer Society of Canada and several other charities, as well as from Pfizer Canada and Sanofi Canada. He receives career support from the Dalhousie Medical Research Foundation as the Kathryn Allen Weldon Professor of Alzheimer Research, and research support from the Nova Scotia Health Research Foundation, the Capital Health Research Fund and the Fountain Family Innovation Fund of the Nova Scotia Health Authority Foundation. The other authors have no conflicts of interest to report. Funding Information: The research was supported by the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Publisher Copyright: {\textcopyright} The Author 2017. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved.",

year = "2017",

month = nov,

day = "1",

doi = "10.1093/ageing/afx150",

language = "English",

volume = "46",

pages = "882--888",

journal = "Age and Ageing",

issn = "0002-0729",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - New horizons in multimorbidity in older adults

AU - Yarnall, Alison J.

AU - Sayer, Avan A.

AU - Clegg, Andrew

AU - Rockwood, Kenneth

AU - Parker, Stuart

AU - Hindle, John V.

N1 - Funding Information: Kenneth Rockwood is President and Chief Science Officer of DGI Clinical, which has contracts with pharma on individualised outcome measurement. In July 2015 he gave a lecture at the Alzheimer Association International Conference in a symposium sponsored by Otsuka and Lundbeck. At that time he presented at an Advisory Board meeting for Nutricia. In 2017 he attended an advisory board meeting for Lundbeck. He is a member of the Research Executive Committee of the Canadian Consortium on Neurodegeneration in Aging, which is funded by the Canadian institutes of Health Research, with additional funding from the Alzheimer Society of Canada and several other charities, as well as from Pfizer Canada and Sanofi Canada. He receives career support from the Dalhousie Medical Research Foundation as the Kathryn Allen Weldon Professor of Alzheimer Research, and research support from the Nova Scotia Health Research Foundation, the Capital Health Research Fund and the Fountain Family Innovation Fund of the Nova Scotia Health Authority Foundation. The other authors have no conflicts of interest to report. Funding Information: The research was supported by the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Publisher Copyright: © The Author 2017. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - The concept of multimorbidity has attracted growing interest over recent years, and more latterly with the publication of specific guidelines on multimorbidity by the National Institute for Health and Care Excellence (NICE). Increasingly it is recognised that this is of particular relevance to practitioners caring for older adults, where multimorbidity may be more complex due to the overlap of physical and mental health disorders, frailty and polypharmacy. The overlap of frailty and multimorbidity in particular is likely to be due to the widespread health deficit accumulation, leading in some cases to functional impairment. The NICE guidelines identify 'target groups' who may benefit from a tailored approach to care that takes their multimorbidity into account, and make a number of research recommendations. Management includes a proactive individualised assessment and care plan, which improves quality of life by reducing treatment burden, adverse events, and unplanned or uncoordinated care.

AB - The concept of multimorbidity has attracted growing interest over recent years, and more latterly with the publication of specific guidelines on multimorbidity by the National Institute for Health and Care Excellence (NICE). Increasingly it is recognised that this is of particular relevance to practitioners caring for older adults, where multimorbidity may be more complex due to the overlap of physical and mental health disorders, frailty and polypharmacy. The overlap of frailty and multimorbidity in particular is likely to be due to the widespread health deficit accumulation, leading in some cases to functional impairment. The NICE guidelines identify 'target groups' who may benefit from a tailored approach to care that takes their multimorbidity into account, and make a number of research recommendations. Management includes a proactive individualised assessment and care plan, which improves quality of life by reducing treatment burden, adverse events, and unplanned or uncoordinated care.

UR - http://www.scopus.com/inward/record.url?scp=85034217984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034217984&partnerID=8YFLogxK

U2 - 10.1093/ageing/afx150

DO - 10.1093/ageing/afx150

M3 - Article

C2 - 28985248

AN - SCOPUS:85034217984

SN - 0002-0729

VL - 46

SP - 882

EP - 888

JO - Age and Ageing

JF - Age and Ageing

IS - 6

ER -

New horizons in multimorbidity in older adults

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

PubMed: MeSH publication types

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto